DSD-C118

Congenital adrenal hyperplasia · 46,XX · DSD-C118

DSD-C118 · Congenital adrenal hyperplasia · 2018

Genes CYP21A2 · Karyotype 46,XX · Phenotypes HPO:0000771, Gynecomastia (HP:0000771)

Classic salt-wasting 21-hydroxylase deficiency (congenital adrenal hyperplasia), CYP21A2 R356W homozygous mutation, 46,XX female pseudohermaphroditism (fetal androgen excess causing virilized external genitalia).

Images · 2

Case fields and evidence

Category

Congenital adrenal hyperplasia

Age

16 days (initial visit) to 4 months (vaginal bleeding)

Sex

46,XX, identified at birth due to ambiguous genitalia, reared as female

Karyotype

46,XX

Genetics

CYP21A2

Phenotypes

Gynecomastia (HP:0000771)

Diagnosis

Classic salt-wasting 21-hydroxylase deficiency (congenital adrenal hyperplasia), CYP21A2 R356W homozygous mutation, 46,XX female pseudohermaphroditism (fetal androgen excess causing virilized external genitalia).

Follow-up

Three months postoperatively metabolic control good (FSH 2.8, LH<0.07, E2<11.8, T<10); uterus still infantile (31x7x8 mm); no recurrent vaginal bleeding within 8 months.

General phenotype

At 16 days: good general condition; at 4 months: no breast development or pubic hair, large mass palpable in right hemiabdomen (extending from upper abdomen to inguinal region).

Imaging

Ultrasound (at diagnosis): infantile uterus and ovaries, adrenal hypertrophy; at 4 months: uterus 30x12x11 mm (no body-cervix distinction), endometrial thickness 1.5 mm, left ovary 26x10x11 mm with multiple follicles (max 5 mm), right ovary 90x80x60 mm giant uniloculated cyst with thin ovarian parenchyma.

Laboratory findings

Na+: 126 mEq/L (ref 132-147; timing at diagnosis); K+: 6.87 mEq/L (ref 3.6-6.1; timing at diagnosis); Renin: 132 pg/mL (ref 5.3-99; timing at diagnosis); ACTH: 207 pg/mL (ref 0-46; timing at diagnosis); Cortisol: 7.8 ug/dL (ref 9.1-21; timing at diagnosis); 17-OHP: 21 ng/mL (ref 0.53-1.86; timing at diagnosis); Androstenedione: 5.1 ng/mL (ref 0.18-0.80; timing at diagnosis); Testosterone: 1188 ng/dL (ref 0-40; timing at diagnosis); DHEAS: >1500 ug/dL (ref 1-45; timing at diagnosis); FSH (4mo): 4.8 mIU/mL (ref 1.1-2.4; timing 4 months); LH (4mo): 2.7 mIU/mL (ref 0-1.3; timing 4 months); Estradiol (4mo): 55.3 pg/mL (ref 0-15; timing 4 months); Karyotype: 46,XX (timing at diagnosis); CYP21A2: R356W homozygous mutation (ref classic salt-wasting; timing at diagnosis)

Management

Hydrocortisone + fludrocortisone replacement started at diagnosis; at 4 months right ovarian cystectomy + left small cyst aspiration; postoperative continued replacement to maintain metabolic control.

Pathology

Cyst resection histology: follicular cysts; left small cyst also follicular cyst.

Evidence level

See source

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Limitations

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia · 46,XX · DSD-C118 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C118?version=v1.4.0